Patterns in the costs of hospital in-patient care and in-patient drug treatment of 121 symptomatic, HIV-infected patients are described for a university hospital between 1987 and 1991.
Trend analyses have been performed on quarterly and yearly data using parametric and non-parametric statistical techniques.
During the 5-year study period the demand for hospital beds almost quadrupled despite a constant number of admissions per person-year and a 40% decrease in the average length of stay.
The demand for beds was highest in the autumn and winter months.
The impact of female and/or heterosexual subgroups on the yearly utilization of resources increased and reasons for hospitalization became more diverse ; there were fewer hospitalizations for Pneumocystis carinii pneumonia infection.
Antimicrobial drug treatment accounted for the increased drug treatment costs.
The implications for AIDS-treating specialists, hospital managers, and scenario analysts are discussed.
Mots-clés Pascal : SIDA, Séropositivité, Hospitalisation, Admission hôpital, Chimiothérapie, Prescription médicale, Traitement, Analyse coût, Economie santé, Etude longitudinale, Hôpital général, Homme, Virose, Infection, Immunopathologie, Immunodéficit
Mots-clés Pascal anglais : AIDS, Seropositivity, Hospitalization, Hospital admission, Chemotherapy, Medical prescription, Treatment, Cost analysis, Health economy, Follow up study, General hospital, Human, Viral disease, Infection, Immunopathology, Immune deficiency
Notice produite par :
Inist-CNRS - Institut de l'Information Scientifique et Technique
Cote : 95-0437269
Code Inist : 002B30A01C. Création : 01/03/1996.